FDA Import Refusal AEK-0801351-6/41/1 — Windlas Healthcare Private Limited
The FDA refused shipment AEK-0801351-6/41/1 from Windlas Healthcare Private Limited (India) on March 18, 2022. The refused product falls under Drugs and Biologics — VALSARTAN (ANTI-HYPERTENSIVE - PART II). Cited charge: 27 This firm has 4 other import refusals on record.
Refusal Details
- Date
- March 18, 2022
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62OCY12 VALSARTAN (ANTI-HYPERTENSIVE - PART II)
- Charges
- 27